Adjuvant combination formulations

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 39/00 (2006.01) A61K 39/095 (2006.01) A61K 39/155 (2006.01) A61K 39/21 (2006.01) A61K 39/35 (2006.01)

Patent

CA 2372181

The use of 3-O-deacylated monophosphoryl lipid A or monophosphoryl lipid A and derivatives and analogs thereof, in combination with a cytokine or lymphokine such as granulocyte macrophage colony stimulating factor or interleukin-12 is useful as an adjuvant combination in an antigenic composition to enhance the immune response in a vertebrate host to a selected antigen.

L'invention concerne un monophosphoryl lipide A 3-0-désacétylé ou un monophosphoryl lipide A et des dérivés et analogues de ceux-ci, utilisés en combinaison avec une cytokine ou une lymphokine, notamment un facteur stimulant les colonies de granulocytes macrophages ou l'interleukine-12. Cette préparation est utilisée comme combinaison d'adjuvants dans une composition antigénique afin d'améliorer, chez un vertébré, la réponse immunitaire à un antigène choisi.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adjuvant combination formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adjuvant combination formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvant combination formulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1561546

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.